I was referring to leronlimab......couldn’t reme
Post# of 148187
(Total Views: 343)
Posted On: 08/27/2019 10:52:34 PM
I was referring to leronlimab......couldn’t remember if it was no resistance or negligible levels, so I went with the safe answer. Significantly less than current HAART drugs and not sure how it compares to Maraviroc.
There was a good chart somewhere, I wish CytoDyn would publish on their website or investor slides to compare to other CCR5 inhibitors. The differences are drastic and I don’t think they advertise the safety enough.....efficacy is important, but combined with being extremely safe makes it a game changer.
There was a good chart somewhere, I wish CytoDyn would publish on their website or investor slides to compare to other CCR5 inhibitors. The differences are drastic and I don’t think they advertise the safety enough.....efficacy is important, but combined with being extremely safe makes it a game changer.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼